Literature DB >> 25468272

Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma.

Matthew L Kelso1, Bret R Elliott2, Nicole A Haverland2, R Lee Mosley2, Howard E Gendelman3.   

Abstract

Neurodegeneration after traumatic brain injury is facilitated by innate and adaptive immunity and can be harnessed to affect brain repair. In mice subjected to controlled cortical impact (CCI), we show that treatment with granulocyte macrophage colony stimulating factor (GM-CSF) affects regulatory T cell numbers in the cervical lymph nodes coincident with decreased lesion volumes and increased cortical tissue sparing. This paralleled increases in neurofilament and diminished reactive microglial staining. Transcriptomic analysis showed that GM-CSF induces robust immune neuroprotective responses seven days following CCI. Together, these results support the therapeutic potential of GM-CSF for TBI.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immunity; Microglia; Neuroinflammation; T cell; Traumatic brain injury

Mesh:

Substances:

Year:  2014        PMID: 25468272      PMCID: PMC4297700          DOI: 10.1016/j.jneuroim.2014.11.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  52 in total

1.  Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.

Authors:  Maria Liljefors; Bo Nilsson; Håkan Mellstedt; Jan-Erik Frödin
Journal:  Cancer Immunol Immunother       Date:  2007-08-04       Impact factor: 6.968

2.  Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.

Authors:  Ashley D Reynolds; Rebecca Banerjee; Jianou Liu; Howard E Gendelman; R Lee Mosley
Journal:  J Leukoc Biol       Date:  2007-08-03       Impact factor: 4.962

3.  Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.

Authors:  Prasanta K Dash; Santhi Gorantla; Howard E Gendelman; Jaclyn Knibbe; George P Casale; Edward Makarov; Adrian A Epstein; Harris A Gelbard; Michael D Boska; Larisa Y Poluektova
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

4.  Distribution of granulocyte-monocyte colony-stimulating factor and its receptor α-subunit in the adult human brain with specific reference to Alzheimer's disease.

Authors:  Sami Ridwan; Henrike Bauer; Katrin Frauenknecht; Harald von Pein; Clemens J Sommer
Journal:  J Neural Transm (Vienna)       Date:  2012-03-20       Impact factor: 3.575

5.  Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation.

Authors:  David J Loane; Alok Kumar; Bogdan A Stoica; Rainier Cabatbat; Alan I Faden
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

6.  Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model.

Authors:  Toru Nakagawa; Sadao Suga; Takeshi Kawase; Masahiro Toda
Journal:  Brain Res       Date:  2006-05-05       Impact factor: 3.252

7.  The role of excitatory amino acids and NMDA receptors in traumatic brain injury.

Authors:  A I Faden; P Demediuk; S S Panter; R Vink
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

8.  GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

Authors:  Lisa M Kosloski; Elizabeth A Kosmacek; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2013-10-29       Impact factor: 3.478

9.  Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model.

Authors:  A M Palmer; D W Marion; M L Botscheller; P E Swedlow; S D Styren; S T DeKosky
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

10.  Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice.

Authors:  Matthew L Kelso; Stephen W Scheff; James R Pauly; Charles D Loftin
Journal:  BMC Neurosci       Date:  2009-08-31       Impact factor: 3.288

View more
  14 in total

1.  Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice.

Authors:  Tomomi Kiyota; Jatin Machhi; Yaman Lu; Bhagyalaxmi Dyavarshetty; Maryam Nemati; Izumi Yokoyama; R L Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2018-03-17       Impact factor: 3.478

Review 2.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

3.  Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation.

Authors:  Zsofia I Kovacs; Saejeong Kim; Neekita Jikaria; Farhan Qureshi; Blerta Milo; Bobbi K Lewis; Michele Bresler; Scott R Burks; Joseph A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-19       Impact factor: 11.205

4.  Deep Brain Stimulation of the Interposed Nucleus Reverses Motor Deficits and Stimulates Production of Anti-inflammatory Cytokines in Ataxia Mice.

Authors:  Gajendra Kumar; Pallavi Asthana; Wing Ho Yung; Kin Ming Kwan; Chung Tin; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2022-05-17       Impact factor: 5.590

Review 5.  Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.

Authors:  Katherine E Olson; Howard E Gendelman
Journal:  Curr Opin Pharmacol       Date:  2015-11-11       Impact factor: 5.547

6.  Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease.

Authors:  Katherine E Olson; Krista L Namminga; Yaman Lu; Mackenzie J Thurston; Aaron D Schwab; Seymour de Picciotto; Sze-Wah Tse; William Walker; Jared Iacovelli; Clayton Small; Brian T Wipke; R Lee Mosley; Eric Huang; Howard E Gendelman
Journal:  Biomaterials       Date:  2021-03-31       Impact factor: 12.479

7.  Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses.

Authors:  Scott R Burks; Cymon N Kersch; Jaclyn A Witko; Michael A Pagel; Maggie Sundby; Leslie L Muldoon; Edward A Neuwelt; Joseph A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

8.  Neuroprotective Activities of Long-Acting Granulocyte-Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice.

Authors:  Katherine E Olson; Krista L Namminga; Aaron D Schwab; Mackenzie J Thurston; Yaman Lu; Ashley Woods; Lei Lei; Weijun Shen; Feng Wang; Sean B Joseph; Howard E Gendelman; R Lee Mosley
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088

9.  Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.

Authors:  Katherine E Olson; Lisa M Kosloski-Bilek; Kristi M Anderson; Breha J Diggs; Barbara E Clark; John M Gledhill; Scott J Shandler; R Lee Mosley; Howard E Gendelman
Journal:  J Neurosci       Date:  2015-12-16       Impact factor: 6.167

10.  Superior Cervical Ganglia Neurons Induce Foxp3+ Regulatory T Cells via Calcitonin Gene-Related Peptide.

Authors:  Kirsten Szklany; Evelyn Ruiter; Firoz Mian; Wolfgang Kunze; John Bienenstock; Paul Forsythe; Khalil Karimi
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.